United Asset Strategies, Inc. Q2 2022 Filing

Filed August 15, 2022

Portfolio Value

$686.2M

Holdings

207

Report Date

Q2 2022

Filing Type

13F-HR

All Holdings (207 positions)

#	Stock	Shares	Value	% Portfolio
201	HUMAHUMACYTE INC	14,960	$48K	0.01%
202	—META MATERIALS INC	30,000	$31K	0.00%
203	—ACORDA THERAPEUTICS INC	27,100	$13K	0.00%
204	—ALKALINE WTR CO INC	30,000	$12K	0.00%
205	NRXPWNRX PHARMACEUTICALS INC	18,300	$11K	0.00%
206	SNDLEURSUNDIAL GROWERS INC	26,000	$8K	0.00%
207	NBYNOVABAY PHARMACEUTICALS INC	10,870	$3K	0.00%

PreviousPage 3 of 3